Bayview Pharmacy's Erythromycin 3%/Tretinoin 0.05% Topical Cream is a specially compounded formulation designed to treat a range of skin conditions. This unique combination of Erythromycin, an antibiotic, and Tretinoin, a retinoid, is particularly effective in managing acne, rosacea, and other inflammatory skin conditions. Erythromycin works by reducing the number of bacteria on the skin, while Tretinoin aids in reducing inflammation and promoting skin cell turnover. Together, these active ingredients work synergistically to alleviate the severity of acne and other skin conditions.

This topical cream is dispensed in a pump mechanism, ensuring convenient and controlled application on the skin. It is designed for localized treatment, allowing for targeted absorption of the active ingredients. This formulation is safe and effective for use in adults and children over the age of 12. It is recommended to apply the cream to the affected area twice daily. Please note that it may take several weeks to observe the full effects of the medication.

Patients should be aware that this medication may cause skin irritation, redness, and dryness. It is always recommended to test a small amount of the cream on the skin before full application. If any adverse reactions occur, discontinue use and consult with a healthcare professional.

If you have any questions or concerns about Bayview Pharmacy's Erythromycin 3%/Tretinoin 0.05% Topical Cream, please do not hesitate to reach out to us. Our team of compounding pharmacists is here to provide the necessary guidance and support. We are committed to ensuring that you receive the most appropriate and effective treatment for your skin condition.

Erythromycin 3%/Tretinoin 0.05% Topical Cream is a compounded formulation specifically designed for the treatment of acne vulgaris. This semisolid preparation is dispensed in a pump mechanism, ensuring a convenient and controlled application on the skin for localized treatment or absorption of the active ingredients.

It is crucial to understand that this combination of medications may increase the risk of skin irritation, dryness, and photosensitivity. Therefore, patients are strongly advised to use a sunscreen and limit sun exposure while using this medication. It is also recommended to avoid using other topical medications, such as benzoyl peroxide, concurrently with this combination to prevent potential adverse reactions.

Patients should also be cautious not to apply this medication on areas of the skin that are broken or irritated. In case of any adverse reactions, it is important to immediately contact a healthcare provider for guidance and potential treatment adjustments.

Furthermore, this combination of medications may interact with certain other medications, such as oral tetracyclines. Therefore, patients are advised to discuss any other medications they are currently taking with their healthcare provider prior to using this medication. This is to ensure safe and effective use of the medication, and to prevent any potential drug interactions.

Remember, your health and safety are our utmost priority. If you have any questions or concerns regarding this medication, please do not hesitate to reach out to your healthcare provider.

Erythromycin 3%/Tretinoin 0.05% Topical Cream is a compounded formulation designed to combat acne. This dual-action medication combines the antibacterial properties of Erythromycin with the sebum-reducing effects of Tretinoin, a derivative of vitamin A. The cream works by reducing inflammation, eliminating acne-causing bacteria, and decreasing the production of sebum, an oily substance that can block pores and contribute to acne development.

The cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin. This ensures that the active ingredients are localized to the area of treatment, enhancing their effectiveness. It is crucial to follow the instructions provided by your healthcare provider when using this medication. Typically, the cream should be applied to the affected area once or twice daily, as directed.

When applying Erythromycin 3%/Tretinoin 0.05% Topical Cream, it is important to avoid contact with the eyes, mouth, and other mucous membranes. Additionally, excessive sun exposure should be avoided while using this medication, as it can increase the risk of sunburn. It is also worth noting that this medication may take several weeks to show noticeable improvement in acne. Therefore, it is essential to continue using the medication as directed, even if there is no immediate improvement.

If you have any questions or concerns about using Erythromycin 3%/Tretinoin 0.05% Topical Cream, please do not hesitate to reach out to your healthcare provider or pharmacist. They can provide you with the necessary guidance and support to ensure that you are using the medication safely and effectively.

Erythromycin 3%/Tretinoin 0.05% Topical Cream is a compounded formulation that has been utilized off-label for the management of various skin conditions. These include psoriasis, a chronic skin disease characterized by red patches covered with silvery scales; lichen planus, an inflammatory condition that can affect the skin and mucous membranes; and pityriasis rosea, a skin rash that usually begins as a large circular or oval spot on the chest, abdomen, or back.

This formulation has also been used to treat perioral dermatitis, a facial rash that tends to occur around the mouth. It is characterized by redness, scaling, and small bumps. Additionally, it has been applied for the treatment of atopic dermatitis, a chronic skin condition that causes red, itchy, and scaly patches, often occurring in individuals with a personal or family history of allergies, asthma, or atopic dermatitis.

Furthermore, Erythromycin 3%/Tretinoin 0.05% Topical Cream has been used to manage contact dermatitis, a skin condition caused by contact with an irritant or allergen, resulting in a red, itchy rash. Lastly, this formulation has been used to treat folliculitis, an infection and inflammation of the hair follicles that can occur anywhere on the skin.

It is crucial to understand that the safety and efficacy of this formulation for these off-label uses have not been conclusively established. Patients are advised to consult with their healthcare provider before using this formulation for any of these off-label uses. If you have any questions about the use of this formulation for any of these off-label uses, it is recommended to seek advice from a healthcare professional.